Kaleido, insulin pump therapy designed to help you live life on your own terms51-200 Employees
- Growth StageExpanding market presence
- Website
- Location
- Company size
- 51-200 people
- Company type
- Medical Device
- Market
ViCentra Funding
Corne Jansen + 1 more2 investors
Investors of ViCentra
Early stage investor (focus on Series A), looking at Enterprise Software, Fintech, Marketplaces and deep technology
INKEF Capital
Early stage investor in Technology and Lifescience with a focus on Series A